Kalvista Pharmaceuticals
Price & Volume
Stats
See more52W Range | $7.30-$17.28 |
Market Cap | $551.7M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $1.4M |
Revenue Growth (YoY) | 30.7% |
Gross Profit (12 Mos) | -$59.4M |
Diluted EPS | -$3.94 |
News
See moreYahoo Finance • 14 days ago
KalVista prices upsized offering of $125M of 3.250% notes due 2031
Yahoo Finance • 15 days ago
KalVista to offer $110M in convertible notes; shares down 10%
Yahoo Finance • 28 days ago
Stocks Rally and Bond Yields Fall on Fed Rate Cut Hopes
Yahoo Finance • 28 days ago
Stocks Climb as US Labor Market Weakness Bolsters Fed Rate Cut Expectations
About
CEO | Mr. Benjamin L. Palleiko |
Address | 55 Cambridge Parkway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
